Sanjeev Luther, CEO and Board Member of Rafael Pharmaceuticals, pictured above. BioSpace recently spoke with Sanjeev Luther, CEO and board […]
Read the postApproximately 7,000 rare diseases affect 350-500 million people worldwide. The majority of these (80%) are monogenic, so-called because these genetic […]
Read the postA new immune deficiency illness came on the scene in 1981. In the years immediately following, four questions arose that […]
Read the postIn the forty years since the HIV/AIDS pandemic began in 1981, researchers have learned a lot about this disease that […]
Read the postPhoto courtesy of Kazia Therapeutics. BioSpace recently spoke with Dr. James Garner, CEO of Kazia Therapeutics, an oncology company that […]
Read the post